Lung cancer vaccine: How does it work?

Lung cancer vaccine: How does it work?

The phase one clinical trial will take place at 34 sites across seven countries. Picture: Aaron Chown/PA Wire

A trial to determine the safety of a novel vaccine for lung cancer will take place at sites across England and Wales.

The first UK patient received the jab at the National Institute for Health Research UCLH Clinical Research Facility on Tuesday.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited